Literature DB >> 21389334

Shooting up: the interface of microbial infections and drug abuse.

Karishma S Kaushik1, Ketoki Kapila2, A K Praharaj3.   

Abstract

Illicit drug control has been on the global agenda for more than a century. Infections have long been recognized as one of the most serious complications of drug abuse. Drug users are susceptible to pulmonary, endovascular, skin and soft tissue, bone and joint, and sexually transmitted infections caused by a wide range of bacterial, viral, fungal and protozoal pathogens. In addition, injection drug users are at increased risk for parenterally acquired infections such as human immunodeficiency virus, hepatitis B virus, hepatitis C virus, tetanus and malaria. Factors related to drug use, such as unsterile injection practices, contaminated drug paraphernalia and drug adulterants, increase the exposure to microbial pathogens. Illicit drugs also affect several components of the complex immune system and thus modulate host immunity. In addition, lifestyle practices such as multiple sexual partners, overcrowded housing arrangements and malnutrition serve as co-factors in increasing the risk of infection. In this review we present an overview of the unique aspects of microbial pathogenesis, immune modulation and common infections associated with drug use. We have restricted the definition of drug abuse to the use of illegal drugs (such as opiates, marijuana, cocaine, heroin and amphetamines), not including alcohol and nicotine.

Entities:  

Mesh:

Year:  2011        PMID: 21389334     DOI: 10.1099/jmm.0.027540-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  21 in total

1.  Skin and needle hygiene intervention for injection drug users: results from a randomized, controlled Stage I pilot trial.

Authors:  Kristina T Phillips; Michael D Stein; Bradley J Anderson; Karen F Corsi
Journal:  J Subst Abuse Treat       Date:  2012-02-14

2.  Identifying and Addressing the Unmet Health Care Needs of Drug Court Clients.

Authors:  Karen L Dugosh; David S Festinger; Jessica L Lipkin
Journal:  J Subst Abuse Treat       Date:  2016-08-28

Review 3.  Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.

Authors:  Sabita Roy; Jana Ninkovic; Santanu Banerjee; Richard Gene Charboneau; Subhas Das; Raini Dutta; Varvara A Kirchner; Lisa Koodie; Jing Ma; Jingjing Meng; Roderick A Barke
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-26       Impact factor: 4.147

4.  Drugs of abuse effects on immunity and microbial pathogenesis.

Authors:  Sabita Roy
Journal:  J Neuroimmune Pharmacol       Date:  2011-10-14       Impact factor: 4.147

5.  Opiate Injection-associated Infective Endocarditis in the Southeastern United States.

Authors:  Lauren Hartman; Erin Barnes; Laura Bachmann; Katherine Schafer; James Lovato; Daniel Clark Files
Journal:  Am J Med Sci       Date:  2016-08-23       Impact factor: 2.378

6.  Electronic Health Record-Based Screening for Substance Abuse.

Authors:  Farrokh Alemi; Sanja Avramovic; Mark D Schwartz
Journal:  Big Data       Date:  2018-09-19       Impact factor: 2.128

7.  Sex work, injection drug use, and abscesses: Associations in women, but not men.

Authors:  Alysse G Wurcel; Deirdre Burke; Margie Skeer; David Landy; Robert Heimer; John B Wong; Kenneth K H Chui; Thomas J Stopka
Journal:  Drug Alcohol Depend       Date:  2018-02-20       Impact factor: 4.492

Review 8.  The effects of opioids on the lung.

Authors:  Joshua B Radke; Kelly P Owen; Mark E Sutter; Jonathan B Ford; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

Review 9.  Optimising health and safety of people who inject drugs during transition from acute to outpatient care: narrative review with clinical checklist.

Authors:  Kinna Thakarar; Zoe M Weinstein; Alexander Y Walley
Journal:  Postgrad Med J       Date:  2016-03-22       Impact factor: 2.401

Review 10.  The Clinical Microbiology Laboratory and the Opioid Epidemic: Challenges and Opportunities.

Authors:  Simeon D Kimmel; Nancy S Miller
Journal:  Infect Dis Clin North Am       Date:  2020-09       Impact factor: 5.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.